• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » A Kratom Update

A Kratom Update

January 1, 2017
Joshua Sonkiss, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Joshua Sonkiss, MD Editor-in-chief, The Carlat Addiction Treatment Report

If you have not yet heard of kratom (usually pronounced kray-tom or krah-tom), consider this an introduction to an herbal supplement that will likely be popping up in your newsfeeds with increasing frequency. Kratom (Mitragyna speciosa) is a tropical evergreen tree in the coffee family that has been used for centuries in Southeast Asia to boost energy and relieve pain. Kratom preparations are gaining popularity among substance users because of the plant’s opioid-like and stimulant properties. As with other opioids, regular use can cause physical dependence as well as withdrawal symptoms similar to opioid withdrawal.

Because of concerns about kratom’s addictive potential, the DEA had proposed classifying it as a Schedule I drug, in the same category as heroin. There was an outcry of protest, however, with many people advocating for its value as an opioid substitute both for pain ­treatment and to help opioid users curb their addictions. In a highly unusual move, the DEA postponed its decision, and as of now kratom is still legally sold (http://tinyurl.com/zttt6by). Since the DEA ban has been placed on the back burner, Florida and New York are considering bans at the state level.

Your patients are likely to obtain kratom either online or directly from “head shops.” It comes in a variety of forms, including leaves, powders, and capsules, with a typical dose costing in the range of $5–$10. On drug user forums such as Erowid, people report a subjective effect of initial stimulation, and later euphoria, with a duration of action around 2 to 4 hours. The main side effects appear to be sedation and nausea. At high doses, people report severe nausea, vomiting, and dizziness. Animal studies suggest there may be less ­respiratory depression with kratom than other opioids, but this has not been studied in humans. There have been deaths reported in users of kratom, though most were using it in conjunction with other substances. It’s worth noting that some prescribers have begun using buprenorphine to treat kratom use disorder. Although kratom won’t show up in routine drug tests, urine testing is available for mitragynine, one of kratom’s main psychoactive ­compounds.

Bottom line: Kratom is a plant with mild opioid-like properties that may well become addictive for some users. Overall, it appears to be less addictive than other opioids, whether prescription painkillers or street drugs. There’s a good chance, however, that it will soon become illegal, at least in some states.
Addiction Treatment
KEYWORDS addiction news_of_note substance-abuse
    Joshua Sonkiss, MD

    Using DBT Skills in Everyday Clinical Practice: An In-Depth Overview for Therapists

    More from this author
    www.thecarlatreport.com
    Issue Date: January 1, 2017
    SUBSCRIBE NOW
    Table Of Contents
    Take The CME Post-Test for Sex Addiction, CATR, January/February 2017
    Cannabis and Psychosis: The Debate Continues
    Sex Addiction: A Primer
    Pornography Addiction
    A Kratom Update
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.